160 related articles for article (PubMed ID: 78893)
1. [Blood volume replacement and hemodilution with hydroxyethyl starch].
Messmer K; Jesch F
Infusionsther Klin Ernahr; 1978 Jun; 5(3):169-77. PubMed ID: 78893
[TBL] [Abstract][Full Text] [Related]
2. [A new hydroxyethyl starch for volume replacement: Elohes 6%].
Medel J; Baron JF
Rev Esp Anestesiol Reanim; 1998 Nov; 45(9):389-96. PubMed ID: 9847657
[TBL] [Abstract][Full Text] [Related]
3. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
Kröll W; Pölz W; Colombo T; Steindorfer P
Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
[TBL] [Abstract][Full Text] [Related]
4. [Volume replacement solutions--pharmacology and clinical use].
Adams HA; Piepenbrock S; Hempelmann G
Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Jan; 33(1):2-17. PubMed ID: 9530478
[TBL] [Abstract][Full Text] [Related]
5. HES 200/0.5 is not HES 200/0.5. Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics.
Treib J; Haass A; Pindur G; Seyfert UT; Treib W; Grauer MT; Jung F; Wenzel E; Schimrigk K
Thromb Haemost; 1995 Dec; 74(6):1452-6. PubMed ID: 8772219
[TBL] [Abstract][Full Text] [Related]
6. [The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers].
Asskali F; Förster H
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Sep; 34(9):537-41. PubMed ID: 10542895
[TBL] [Abstract][Full Text] [Related]
7. Plasma substitutes.
Boldt J; Suttner S
Minerva Anestesiol; 2005 Dec; 71(12):741-58. PubMed ID: 16288182
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetics of middle-molecular hydroxyethyl starch (HAS 200/0,5].
Mishler JM
Infusionsther Klin Ernahr; 1980 Apr; 7(2):96-102. PubMed ID: 6159323
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyethylstarch 200 and 240 differently affect aortic distensibility but not viscosity and blood pressure upon acute isovolumic hemodilution.
Caron A; Hacquard M; Audibert G; Cauchois G; Vigneron C; Stoltz JF; Longrois D; Menu P
Clin Hemorheol Microcirc; 2006; 35(4):447-58. PubMed ID: 17148843
[TBL] [Abstract][Full Text] [Related]
10. [Hydroxyethyl starch--an interim report].
Weidhase R; Faude K; Weidhase R
Anaesthesiol Reanim; 1998; 23(1):4-14. PubMed ID: 9553245
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and biochemical effects of balanced salt-based high molecular weight vs saline-based low molecular weight hydroxyethyl starch solutions during the anhepatic period of liver transplantation.
Ahn HJ; Yang M; Gwak MS; Koo MS; Bang SR; Kim GS; Lee SK
Anaesthesia; 2008 Mar; 63(3):235-42. PubMed ID: 18289228
[TBL] [Abstract][Full Text] [Related]
12. Influence of low and medium molecular weight hydroxyethyl starch on platelets during a long-term hemodilution in patients with cerebrovascular diseases.
Treib J; Haass A; Pindur G; Grauer MT; Treib W; Wenzel E; Schimrigk K
Arzneimittelforschung; 1996 Nov; 46(11):1064-6. PubMed ID: 8955865
[TBL] [Abstract][Full Text] [Related]
13. Resuscitation from hemorrhagic shock with hydroxyethyl starch and coagulation changes.
Cabrales P; Tsai AG; Intaglietta M
Shock; 2007 Oct; 28(4):461-7. PubMed ID: 17558350
[TBL] [Abstract][Full Text] [Related]
14. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
[TBL] [Abstract][Full Text] [Related]
15. [Effect of a new 10% hydroxyethyl starch solution HES/270/0.5 on blood coagulation, blood loss and hemodynamics in comparison with 3.5% PPL].
Penner M; Fingerhut D; Tacke A
Infusionstherapie; 1990 Dec; 17(6):314-8. PubMed ID: 1709146
[TBL] [Abstract][Full Text] [Related]
16. [Decrease of thrombocyte volume after several days infusion of highly substituted medium molecular weight hydroxyethyl starch (HAES 200/0.62)].
Treib J; Haass A; Pindur G; Grauer MT; Wenzel E; Schimrigk K
Wien Klin Wochenschr; 1996; 108(1):20-3. PubMed ID: 8677658
[TBL] [Abstract][Full Text] [Related]
17. [Acetyl starch as volume substitute, a possible alternative to HES].
Asskali F; Warnken U; Förster H
Dtsch Med Wochenschr; 2001 Jan; 126(1-2):1-6. PubMed ID: 11200658
[TBL] [Abstract][Full Text] [Related]
18. [Clinical experiences with a 6% hydroxyethyl starch 40000 solution; metabolic parameters and tolerance].
Kori-Lindner C; Hubert H
Infusionsther Klin Ernahr; 1978 Apr; 5(2):93-8. PubMed ID: 77256
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of 2 6% middle-molecular hydroxyethyl starch solutions on elimination kinetics and flow characteristics of blood in volunteers].
Koscielny J; Jung F; Mrowietz C; Pindur G; Förster H; Schimetta W; Kiesewetter H; Wenzel E
Infusionsther Transfusionsmed; 1994 Aug; 21(4):251-9. PubMed ID: 7524833
[TBL] [Abstract][Full Text] [Related]
20. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]